*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Tivicay 50mg Tablets

Dolutegravir (Dolutegravir Sodium)
50 mg
Tablet

ROA

Oral

Applicant Name

GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)

NRN

B4-5134

Status

Active


ATC Code

J05AJ03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 30  

Product Description

90 RNW-PP-121333 Tivicay 50mg Tablets DOLUTEGRAVIR (AS DOLUTEGRAVIR SODIUM) 50MG Dolutegravir sodium - 52.6mg) (Excipients - D-mannitol {E421} - q.s. {to 145.4}mg, Microcrystalline Cellulose {E460} - 60.0mg, Povidone K29/32 {E1201} - 15.0mg, Sodium starch Glycolate - 21.0mg, Sodium stearyl Fumarate {E365} - 6.0mg, Opadry II Yellow 85F92461 - 9.0mg, Purified water - q.s.) B4-5134 Drugs Imported Products 1*30 Prescription Only Medicine (POM) 3/24/2020 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LIMITED, 1, Industrial Avenue, Ilupeju 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street Ware Hertfordshire SG12 0DJ UK, United Kingdom

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2023-07-06  

Expiry Date

2028-07-05